|
|
|
| A Targeted Molecular Method For Sensitive Viral Detection In Just Days | Designed to detect a wide range of potential contaminants, the Blazar® CHO AOF panel represents a significant advancement in biomanufacturing safety and efficiency. By streamlining the testing process and enhancing reliability, this cutting-edge technology plays a crucial role in accelerating the development of life-changing medicines. Watch this video to discover the inspiring journey behind the development of this innovative solution! |
|
|
|
|
By Tyler Menichiello, chief editor, Bioprocess Online | Just like people, some sponsor-CDMO partnerships can be matches made in heaven. Others, not so much. See what experts have to say about finding the right CDMO and building a successful partnership together. | |
|
|
Lonza Bets On Biologics. What's It Mean For You? | By Louis Garguilo, chief editor, Outsourced Pharma | It’s a large and universally recognizable CDMO, so this matters. Swiss-based powerhouse Lonza will increase its focus on biologics, and “advanced synthesis” including for antibody-drug conjugates (ADCs), cell and gene therapies (CGT), and mRNA therapeutics. Will other CDMOs follow suit? What's this say about the future of development outsourcing and our industry? |
|
|
|
|
|
| Lessons In Scaling Lipids Production And Purification | Article | Curia | The speed at which the pharmaceutical industry is now developing and manufacturing mRNA drug products at large scale is astounding, yet it has highlighted supply chain vulnerabilities to make the required pharmaceutical ingredients such as lipids. |
|
|
|
|
|
| Webinar: Enhancing Protein Quality Through Optimized Galactosylation | Whether you are looking to modify your existing cell culture process or seek solutions to expedite your product's time-to-market, this webinar provides the knowledge and tools you need to achieve your desired protein quality. Learn the importance of proper glycosylation in achieving consistent, desirable protein quality as well as strategies to control and optimize galactosylation profiles in various cell culture processes. Click here to learn more. |
|
|
|
|
|
|
|
|
|
| Single-use systems (SUS) are everywhere—but standardization hasn’t caught up. Join Bioprocess Online Live for a timely discussion on how the lack of SUS standards is impacting implementation, tech transfer, and supply chain stability—and what the industry must do next. Registration is free thanks to the support of CPC. |
|
|
| Connect With Bioprocess Online: |
|
|
|
